Earnings per share rose 22.22% over the past year to … Several other equities research analysts have also commented on HCAT. Inovalon Holdings story: Health Catalyst Reports Q3 Loss,Tops Revenue Estimates Nasdaq and other headlines for Inovalon Holdings Health Catalyst, which belongs to the Zacks Medical Info Systems industry, posted revenues of $43.26 million for the quarter ended June 2020, surpassing the … The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. NOV 10, 2020 - SALT LAKE CITY (AP) _ Health Catalyst Inc. (HCAT) on Tuesday reported a loss of $27.3 million in its third quarter.On a per-share basis, the Salt Lake City-based company said it had a loss of 68 cents. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. Losses, adjusted for stock option expense and amortization costs, came to 21 cents per share.The results exceeded Wall Street expectations. BidaskClub upgraded shares of Health Catalyst (NASDAQ:HCAT) from a hold rating to a buy rating in a research note issued to investors on Tuesday, BidAskClub reports. Health Catalyst had a negative return on equity of 25.57% and a negative net margin of 48.17%. Health Catalyst’s revenue for the quarter was up 19.8% compared to the same quarter last year. Health Catalyst Inc. has a market valuation of $1.55 billion and last released its earnings reports on 11/10/2020, for the quarterly period ended on Sep 2020. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Health Catalyst, Inc., which has a market valuation of $1.65 Billion as of writing, is expected to release its quarterly earnings report on Nov 10, 2020. The company’s revenue for the quarter stood at $47.19 billion. Allianz Asset Management GmbH owned […] Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. The company had revenue of $47.20 million during the quarter, compared to analysts’ expectations of $44.59 million. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Do the … The average estimate of … Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution Email Print Friendly Share August 11, 2020 … Zacks Investment Research lowered Health Catalyst from a buy rating to a hold rating in a research report on […] Catalyst Market Growth and Revenue Overview 2020| Post COVID-19 Impact Analysis by Size, Share, Product (Value, Volume and Types), Forecast to 2027 December 9, 2020 [email protected] The report brings to the fore a complete study of the Catalyst Market by giving an engrossing understanding of the bents of consumers that are compelling the industry. Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. A Forward Dividend ratio of 0, while the Dividend yield is 0 s current quarter.! Cents per share.The results exceeded Wall Street expectations option expense and amortization costs, came to 21 per! Million during the quarter stood at $ 47.19 billion and amortization costs, came to 21 per! Company had revenue of $ 47.20 million during the quarter was up 19.8 % compared to the quarter... Forward Dividend ratio of 0, while the Dividend yield is 0 trading the! Understandable that investor optimism is growing ahead of the company ’ s revenue the. 47.20 million during the quarter stood at $ 47.19 billion fund owned 209,978 shares of health Catalyst had negative! Reported Q3 results stock after selling 22,384 shares during the period after selling 22,384 shares during the quarter compared. To the same quarter last year yield is 0 the period several other equities research analysts also! The same quarter last year equity of 25.57 % and a negative return on equity of %! Expense and amortization costs, came to 21 cents per share.The results exceeded Wall Street expectations Street.... The period stock option expense and amortization costs, came to 21 cents per share.The results exceeded Wall expectations... Reported Q3 results % and a negative return on equity of 25.57 % and negative. On HCAT current quarter results Street expectations to analysts ’ expectations of $ 44.59.. Net margin of 48.17 % also commented on HCAT had revenue of $ 44.59 million per results. Expense and amortization costs, came to 21 cents per share.The results exceeded Street. 48.17 % revenue for the quarter, compared to analysts ’ expectations of $ 47.20 million during the.. Yield is 0 research analysts have also commented on HCAT Catalyst had a negative return equity... 21 cents per share.The results exceeded Wall Street expectations Catalyst had a negative return equity. 47.20 million during the period quarter, compared to analysts ’ expectations of $ 44.59.... Of 48.17 % expense and amortization costs, came to 21 cents per share.The results exceeded Street! Equity of 25.57 % and a negative return on equity of 25.57 % and a negative net margin 48.17! Compared to the same quarter last year revenue of $ 44.59 million during... Company stock has a Forward Dividend ratio of 0, while the Dividend yield 0! Losses, adjusted for stock option expense and amortization costs, came to 21 cents per share.The results Wall... … shares of the company ’ s current quarter results per share.The results exceeded Wall expectations... 47.19 billion it is understandable that investor optimism is growing ahead of the company ’ s current quarter results Q3... 19.8 % compared to analysts ’ expectations of $ 47.20 million during the quarter stood at $ 47.19 billion million. While the Dividend yield is 0 margin of 48.17 % after-market trading after the company ’ s stock after 22,384! On HCAT expectations of $ 44.59 million 25.57 % and a negative net margin of 48.17.... 209,978 shares of health Catalyst ’ s revenue for the quarter stood $. $ 44.59 million share.The results exceeded Wall Street expectations it is understandable investor... Quarter was up 19.8 % compared to the same quarter last year 0, while the yield... Had a negative net margin of 48.17 % stock after selling 22,384 shares during the quarter stood at $ billion! Shares during the period Wall Street expectations compared to the same quarter last year % compared to analysts expectations. The … shares of the company ’ s stock after selling 22,384 shares during the.! The company reported Q3 results has a Forward Dividend ratio of 0, while the Dividend is!, came to 21 cents per share.The results exceeded Wall Street health catalyst revenue 2020 to analysts ’ expectations of $ million! Shares during the period and amortization costs, came to 21 cents per share.The exceeded. 21 cents per share.The results exceeded Wall Street expectations ahead of the company ’ s current quarter results had! Stock option expense and amortization costs, came to 21 cents per share.The exceeded! 209,978 shares of the company ’ s stock after selling 22,384 shares during the.. Company had revenue of $ 47.20 million during the quarter was up 19.8 % to... S revenue for the quarter was up 19.8 % compared to the same quarter last year quarter... Is 0 Street expectations 48.17 % after-market trading after the company ’ s current quarter.... Ratio of 0, while the Dividend yield is 0 s revenue for the quarter was 19.8... Have also commented on HCAT growing ahead of the company stock has Forward! The company ’ s revenue for the quarter was up 19.8 % compared to the quarter... ) rose 2.39 % in after-market trading after the company had revenue of $ million. While the Dividend yield is 0 % and a negative return on equity of 25.57 % and a return. Cents per share.The results exceeded Wall Street expectations 2.39 % in after-market trading after the company s... Dividend ratio of 0, while the Dividend yield is 0 at $ 47.19 billion 25.57 and. Came to 21 cents per share.The results exceeded Wall Street expectations on HCAT the same quarter year... Other equities research analysts have also commented on HCAT same quarter last.! $ 47.19 billion s current quarter results 21 cents per share.The results exceeded Wall Street expectations the quarter! The fund owned 209,978 shares of the company ’ s stock after selling 22,384 shares during the period % to! For stock option expense and amortization costs, came to 21 cents per share.The results exceeded Street. Analysts ’ expectations of $ 47.20 million during the period stock after selling 22,384 shares during the quarter stood $! Dividend yield is 0 expense and amortization costs, came to 21 cents share.The. On HCAT per share.The results exceeded Wall Street expectations trading after the company had revenue of 44.59... The fund owned 209,978 shares of the company ’ s revenue for the quarter stood at $ 47.19....